Goodwin

Partner

Alexander Varond is a partner in Goodwin’s Technology and Life Sciences groups and a co-chair of the firm’s FDA Litigation practice. Alexander advises drug, biotech, and device clients on a wide range of cutting-edge FDA regulatory matters. He has extensive experience in medical device and drug development, Hatch-Waxman patent and exclusivity issues, and regulatory strategy. Alexander also counsels on advertising and promotional issues, defends companies during civil and criminal investigations on a variety of issues, including off-label promotion and GMPs, and regularly advises on corporate transactions. He has received wide recognition, including being named a Top Healthcare Lawyer by the Daily Journal and honored as a Top 40 under 40 lawyer in both California and Washington, DC.

Prior to joining Goodwin in 2017, Alexander was a senior associate at Hyman, Phelps & McNamara, PC. His perspective is bolstered by having worked closely alongside numerous in-house regulatory and legal teams through various critical projects, including NDA and BLA preparation, formal dispute resolutions, FDA meetings, regulatory strategy advisory meetings, and product launches.

JD, 2011, The George Washington University Law School / BS, Biomedical Engineering and Management Science, 2006, University of California, San Diego